Morgan Stanley analyst Ronald Kamdem downgraded Re/Max Holdings to Underweight from Equal Weight with a price target of $9, down from $19.50. The firm feels the NAR ruling “increases the risk of further ligation and costly settlements.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RMAX:
- Re/Max Holdings price target lowered to $14 from $21 at Stephens
- Re/Max Holdings narrows FY23 revenue to $323M-$328M from $320M-$332M
- RE/MAX Holdings sees Q4 revenue $74M-$79M, consensus $75.09M
- Re/Max Holdings reports Q3 adjusted EPS 40c, consensus 36c
- RE/MAX HOLDINGS, INC. REPORTS THIRD QUARTER 2023 RESULTS